Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02684565 · ClinicalTrials.gov registry record · NA
Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02684565 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 11 participants.
The verdict
NCT02684565, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Branching chain amino acids (BCAA) have both beneficial and detrimental effects of on metabolism have been established and therefore warrants further investigation. In the preliminary study, the investigators found that BCAAs enhanced glucose metabolism in lean mice while they promoted glucose intolerance in obese mice. In lean mice, BCAAs decreased adiposity and enhanced glucose utilization and insulin sensitivity in different tissues. But in obese mice, BCAAs' effects were mediated by impaired insulin signaling in fat tissue. This study will examine 10 obese subjects with pre-diabetes and examine the effects of taking BCAA supplement and will monitor the subjects blood glucose, insulin, triglyceride levels and will have an oral glucose tolerance test on repeated occasions to see if any changes are noted in their glucose regulation.
Interventions
- DIETARY_SUPPLEMENT BCAA High Protein supplement
- DIETARY_SUPPLEMENT BCAA Low Protein supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02684565
The ClinicalTrials.gov registry entry for NCT02684565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BCAA High Protein supplement is the first listed.
NCT02684565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02684565 about?
NCT02684565 is a clinical study titled "Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects". Branching chain amino acids (BCAA) have both beneficial and detrimental effects of on metabolism have been established and therefore warrants further investigation. In the preliminary study, the investigators found that BCAAs enhanced glucose metabolism in lean mice while they promoted glucose intol...
What is the current status of trial NCT02684565?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2016-10. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02684565?
The interventions under investigation include: BCAA High Protein supplement (DIETARY_SUPPLEMENT), BCAA Low Protein supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02684565?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.